STUDY OF INCIDENCE OF BLEEDING IN PATIENTS OF AMI AFTER THROMBOLYTIC THERAPY · Abstract : · Keywords : · Article: Download PDF DOI : 10.36106/ijar. Cite This ...
Aug 25, 2023 · Elderly patients with low body weight and females are at increased risk of bleeding following thrombolytic treatment [12]. However, the rate and ...
Intracranial hemorrhage was observed in 24 patients, corresponding to an incidence rate of 1% (95% confidence interval 0.6% to 1.3%). The median time interval ...
Although major bleed was significantly higher in SK and heparin-treated patients (tPA 0.5% vs. SK 1.0%), the overall incidence of stroke was similar in all ...
Missing: "IJAR -" Research
Several large-scale, placebo-controlled studies have shown that thrombolytic therapy results in a significant reduction in mortality for patients with acute ...
Jul 25, 2001 · An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med.1993;329:673-682 ...
Missing: "IJAR -" | Show results with:"IJAR -"
Dec 1, 2001 · Severe bleeding occurred in 58 patients (0·7%) in the bivalirudin group versus 40 patients (0·5%) in the heparin group (p=0·07), and ...
Oct 13, 2020 · Serious bleeding complications, especially intracranial bleeding, limited recanalization rates, and rapid clearance requiring a 1- to 3-hour ...
This study aimed to assess the knowledge and practice of nurses regarding thrombolytic therapy for patients with acute myocardial infarction (AMI) in.
Activase® (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms ...
